A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...] …
Blog Posts
Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Oklahoma Gov. Kevin Stitt (R) on Saturday vetoed a 340B contract pharmacy access despite it passing the Republican-controlled state legislature [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Vermont state senators voted by voice Thursday to pass a 340B contract pharmacy access bill with recently added reporting requirements [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Breaking News
Federal Judge Upholds HHS’ Right to Pre-Approve 340B Rebates, Tosses Four of Five Drugmaker Lawsuits
A federal district judge has upheld the federal government’s authority to require agency approval of drugmaker 340B rebate models, dealing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program—which 340B Report broke [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key hospital group recently urged Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. to reject drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key U.S. House Committee voted along party lines Wednesday to approve the GOP’s wide-ranging health care reconciliation budget provisions—some [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
With a Saturday deadline looming, Oklahoma Gov. Kevin Stitt (R) is facing pressure from dark money groups and drug industry-funded [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Ohio this week became the latest state to consider legislation to block drug manufacturers from restricting 340B contract pharmacy arrangements. [...] …